Downregulation ofmiR-29contributes to cisplatin resistance of ovarian cancer cells

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The role of miRNA-29 family in cancer

(2013) Yang Wang et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

microRNA involvement in human cancer

(2012) M. V. Iorio et al.   CARCINOGENESIS

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

(2012) M. T. Di Martino et al.   CLINICAL CANCER RESEARCH

miR-210: a therapeutic target in cancer

(2012) Liu Hong et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Growth Inhibition of Ovarian Tumor-Initiating Cells by Niclosamide

(2012) Y.-T. Yo et al.   MOLECULAR CANCER THERAPEUTICS

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4

(2012) D M Cittelly et al.   ONCOGENE

miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression

(2011) Da-Peng Ding et al.   CARCINOGENESIS

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy

(2011) M. Garofalo et al.   CURRENT MOLECULAR MEDICINE

MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression

(2011) Jian-Hong Fang et al.   HEPATOLOGY

MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance

(2011) G. Ye et al.   JOURNAL OF CELL SCIENCE

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

(2011) Qingqing Ding et al.   JOURNAL OF CLINICAL INVESTIGATION

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1

(2011) Fanfei Kong et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

(2011) Can Liu et al.   NATURE MEDICINE

MicroRNAs in body fluids—the mix of hormones and biomarkers

(2011) Maria Angelica Cortez et al.   Nature Reviews Clinical Oncology

MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK)

(2011) S Zhang et al.   ONCOGENE

MicroRNA-29, a key regulator of collagen expression in systemic sclerosis

(2010) Britta Maurer et al.   ARTHRITIS AND RHEUMATISM

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

(2010) J.-J. Zhao et al.   BLOOD

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant

(2010) L Hu et al.   BRITISH JOURNAL OF CANCER

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

(2010) Christoph Roderburg et al.   HEPATOLOGY

Targeting microRNAs in cancer: rationale, strategies and challenges

(2010) Ramiro Garzon et al.   NATURE REVIEWS DRUG DISCOVERY

MicroRNA 29b functions in acute myeloid leukemia

(2009) R. Garzon et al.   BLOOD

Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients

(2009) Ram Eitan et al.   GYNECOLOGIC ONCOLOGY

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

(2009) David S. Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents

(2009) D. R. Cochrane et al.   MOLECULAR CANCER THERAPEUTICS

MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer

(2008) N. Yang et al.   CANCER RESEARCH

MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN

(2008) H. Yang et al.   CANCER RESEARCH

Role of microRNAs in drug-resistant ovarian cancer cells

(2008) Antonio Sorrentino et al.   GYNECOLOGIC ONCOLOGY

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

(2008) S. Sengupta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

(2008) E. van Rooij et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA